B
BioLogiQ
Plastics manufacturing company
About BioLogiQ
BioLogiQ operates in the sustainable plastics industry, focusing on creating environmentally friendly biopolymer solutions. The company produces BioPolymers in pellet form, which can be used by plastic product manufacturers with their existing equipment, eliminating the need for costly upgrades. BioLogiQ's flagship product, NuPlastiQ, blends easily with traditional and bioplastic resins to create BioBlends. These blends offer enhanced physical and environmental performance characteristics compared to traditional plastics, such as increased strength, reduced thickness, and a stable shelf life. The company's solutions help lower greenhouse gas emissions and reduce the carbon footprint of plastic products. BioLogiQ primarily serves plastic product manufacturers looking to improve sustainability and add value to their brands. The business model revolves around selling biopolymer pellets to these manufacturers, generating revenue through product sales.
Source: Dealroom company dataAt a glance
- Founded
- 2011
- Headquarters
- Idaho Falls, United States
- Sector
- Marketing
News
Open roles
BioLogiQ in the Idaho Falls ecosystem
The BioLogiQ office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
US Department of Agriculture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about BioLogiQ on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See BioLogiQ on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

